DE2751258A1 - Trisubstituierte 1-phenyl-2,3,4,5- tetrahydro-1h-3-benzazepine und deren salze, verfahren zu ihrer herstellung und ihre verwendung als arzneistoffe - Google Patents

Trisubstituierte 1-phenyl-2,3,4,5- tetrahydro-1h-3-benzazepine und deren salze, verfahren zu ihrer herstellung und ihre verwendung als arzneistoffe

Info

Publication number
DE2751258A1
DE2751258A1 DE19772751258 DE2751258A DE2751258A1 DE 2751258 A1 DE2751258 A1 DE 2751258A1 DE 19772751258 DE19772751258 DE 19772751258 DE 2751258 A DE2751258 A DE 2751258A DE 2751258 A1 DE2751258 A1 DE 2751258A1
Authority
DE
Germany
Prior art keywords
tetrahydro
benzazepine
group
phenyl
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19772751258
Other languages
German (de)
English (en)
Other versions
DE2751258C2 (US20080293856A1-20081127-C00150.png
Inventor
Joseph Weinstock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Corp filed Critical SmithKline Corp
Publication of DE2751258A1 publication Critical patent/DE2751258A1/de
Application granted granted Critical
Publication of DE2751258C2 publication Critical patent/DE2751258C2/de
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00Compounds having —CHO groups
    • C07C47/52Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/575Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D497/00Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/02Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D497/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE19772751258 1976-11-17 1977-11-16 Trisubstituierte 1-phenyl-2,3,4,5- tetrahydro-1h-3-benzazepine und deren salze, verfahren zu ihrer herstellung und ihre verwendung als arzneistoffe Granted DE2751258A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/742,965 US4160765A (en) 1976-11-17 1976-11-17 Method for 6-bromination of 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds

Publications (2)

Publication Number Publication Date
DE2751258A1 true DE2751258A1 (de) 1978-06-01
DE2751258C2 DE2751258C2 (US20080293856A1-20081127-C00150.png) 1990-01-04

Family

ID=24986959

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19772751258 Granted DE2751258A1 (de) 1976-11-17 1977-11-16 Trisubstituierte 1-phenyl-2,3,4,5- tetrahydro-1h-3-benzazepine und deren salze, verfahren zu ihrer herstellung und ihre verwendung als arzneistoffe

Country Status (37)

Country Link
US (1) US4160765A (US20080293856A1-20081127-C00150.png)
JP (3) JPS5363335A (US20080293856A1-20081127-C00150.png)
AR (1) AR224495A1 (US20080293856A1-20081127-C00150.png)
AT (1) AT362379B (US20080293856A1-20081127-C00150.png)
AU (1) AU509754B2 (US20080293856A1-20081127-C00150.png)
BE (1) BE860774A (US20080293856A1-20081127-C00150.png)
BG (1) BG30019A3 (US20080293856A1-20081127-C00150.png)
CA (1) CA1092107A (US20080293856A1-20081127-C00150.png)
CH (1) CH635079A5 (US20080293856A1-20081127-C00150.png)
CS (1) CS219333B2 (US20080293856A1-20081127-C00150.png)
CY (1) CY1246A (US20080293856A1-20081127-C00150.png)
DD (1) DD133563A5 (US20080293856A1-20081127-C00150.png)
DE (1) DE2751258A1 (US20080293856A1-20081127-C00150.png)
DK (1) DK156057C (US20080293856A1-20081127-C00150.png)
ES (1) ES464044A1 (US20080293856A1-20081127-C00150.png)
FI (1) FI67374C (US20080293856A1-20081127-C00150.png)
FR (1) FR2371430A1 (US20080293856A1-20081127-C00150.png)
GB (1) GB1595502A (US20080293856A1-20081127-C00150.png)
HU (1) HU176709B (US20080293856A1-20081127-C00150.png)
IE (1) IE46087B1 (US20080293856A1-20081127-C00150.png)
IL (1) IL53377A (US20080293856A1-20081127-C00150.png)
IN (1) IN150172B (US20080293856A1-20081127-C00150.png)
IT (1) IT1126216B (US20080293856A1-20081127-C00150.png)
LU (1) LU78513A1 (US20080293856A1-20081127-C00150.png)
MX (1) MX4682E (US20080293856A1-20081127-C00150.png)
MY (1) MY8500382A (US20080293856A1-20081127-C00150.png)
NL (2) NL185563C (US20080293856A1-20081127-C00150.png)
NO (1) NO147029C (US20080293856A1-20081127-C00150.png)
PH (2) PH13611A (US20080293856A1-20081127-C00150.png)
PL (1) PL109672B1 (US20080293856A1-20081127-C00150.png)
PT (1) PT67260B (US20080293856A1-20081127-C00150.png)
RO (1) RO72905A (US20080293856A1-20081127-C00150.png)
SE (1) SE436646B (US20080293856A1-20081127-C00150.png)
SG (1) SG31784G (US20080293856A1-20081127-C00150.png)
SU (1) SU976847A3 (US20080293856A1-20081127-C00150.png)
YU (1) YU40490B (US20080293856A1-20081127-C00150.png)
ZA (1) ZA775910B (US20080293856A1-20081127-C00150.png)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0022330A2 (en) * 1979-07-10 1981-01-14 Smithkline Beckman Corporation Synergistic antihypertensive compositions
WO2005118549A2 (en) * 2004-06-02 2005-12-15 Glaxo Group Limited Compounds having affinity for dopamine d3 receptor and uses thereof

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4197297A (en) * 1976-11-17 1980-04-08 Smithkline Corporation 6-Halo-7,8-dihydroxy-1-(hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepines
JPS5481290A (en) * 1977-11-17 1979-06-28 Smithkline Corp Benzazepin compound
US4171359A (en) * 1978-04-12 1979-10-16 Smithkline Corporation Benz-tetrasubstituted 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
ZA792043B (en) * 1978-05-08 1980-05-28 Scherico Ltd Esters of substituted 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines,process for the preparation thereof and pharmaceutical compositions containing them
US4251525A (en) * 1979-05-25 1981-02-17 Smithkline Corporation 3-Allyl-7,8-dihydroxy-6-halo-1-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine derivatives
US4285938A (en) * 1979-10-11 1981-08-25 Smithkline Corporation 7,8-Dihydroxy-1-(sulfamylphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine derivatives
US4284556A (en) * 1980-01-31 1981-08-18 Smithkline Corporation 7,8-Amino, hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
US4328153A (en) * 1980-07-17 1982-05-04 Smith Kline Corporation Dopaminergic benzazepines
ATE15762T1 (de) * 1981-12-08 1985-10-15 Smithkline Beckman Corp Pharmazeutische zusammensetzungen mit gehalt an 7,8-dihydroxy-1-(hydroxy-phenyl)-2,3,4,5tetrahydro-1h-3-benzazepin-derivaten und an einem beta-adrenergischen blocker.
US4705862A (en) * 1984-10-05 1987-11-10 Smithkline Beckman Corporation Chemical processes for 2-(2-halo-3,4-dimethoxybenzyl)-5-(4-methoxyphenyl)oxazolidines
US4782163A (en) * 1984-10-05 1988-11-01 Smithkline Beckman Corporation 2-(2-halo-3,4-dimethoxybenzyl)-5-(4-methoxyphenyl)-oxazolidines
US5068326A (en) * 1989-04-03 1991-11-26 Kung Hank F Dopamine receptor ligands and imaging agents
KR20010113006A (ko) * 2000-06-15 2001-12-24 주정호 항암제로서 유용한 n-치환된 벤즈아제피닐우레아 유도체및 그의 제조방법
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
US7090830B2 (en) 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US7766013B2 (en) 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7585493B2 (en) 2001-05-24 2009-09-08 Alexza Pharmaceuticals, Inc. Thin-film drug delivery article and method of use
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
JP2007516149A (ja) 2003-05-21 2007-06-21 アレックザ ファーマシューティカルズ, インコーポレイテッド 基板温度の均一性を制御する方法、および、内蔵式加熱ユニットおよびそれを使用する薬剤供給ユニット
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
AU2004322756B2 (en) 2004-08-12 2011-04-14 Alexza Pharmaceuticals, Inc. Aerosol drug delivery device incorporating percussively activated heat packages
CA2593667A1 (en) * 2005-01-24 2006-07-27 Sicor Inc. Process for the preparation of fenoldopam mesylate
US20080216828A1 (en) 2007-03-09 2008-09-11 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
CN104876869B (zh) * 2011-12-22 2017-06-30 四川科伦药物研究院有限公司 一种手性菲诺多泮的拆分方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1118688A (en) * 1967-02-17 1968-07-03 Scherico Ltd Novel benzazepines and process for making same
US3393192A (en) * 1965-04-26 1968-07-16 Schering Corp Novel benzazepines
DE1695844A1 (de) * 1967-02-21 1972-01-20 Scherico Ltd Neue Benzazepine und Verfahren zu ihrer Herstellung
CH555831A (de) * 1967-02-17 1974-11-15 Scherico Ltd Verfahren zur herstellung von neuen benzazepinen.
US4011319A (en) * 1975-07-02 1977-03-08 Smithkline Corporation Pharmaceutical compositions and methods involving benzazepine derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH498122A (de) * 1968-02-09 1970-10-31 Geigy Ag J R Verfahren zur Herstellung eines neuen Tetrahydroazepinderivates
US3609138A (en) * 1967-12-22 1971-09-28 Ciba Geigy Corp 1-aryl-3-benzazepines

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3393192A (en) * 1965-04-26 1968-07-16 Schering Corp Novel benzazepines
GB1118688A (en) * 1967-02-17 1968-07-03 Scherico Ltd Novel benzazepines and process for making same
CH555831A (de) * 1967-02-17 1974-11-15 Scherico Ltd Verfahren zur herstellung von neuen benzazepinen.
DE1695844A1 (de) * 1967-02-21 1972-01-20 Scherico Ltd Neue Benzazepine und Verfahren zu ihrer Herstellung
US4011319A (en) * 1975-07-02 1977-03-08 Smithkline Corporation Pharmaceutical compositions and methods involving benzazepine derivatives

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0022330A2 (en) * 1979-07-10 1981-01-14 Smithkline Beckman Corporation Synergistic antihypertensive compositions
EP0022330A3 (en) * 1979-07-10 1981-01-21 Smithkline Beckman Corporation Synergistic antihypertensive compositions
WO2005118549A2 (en) * 2004-06-02 2005-12-15 Glaxo Group Limited Compounds having affinity for dopamine d3 receptor and uses thereof
WO2005118549A3 (en) * 2004-06-02 2006-04-13 Glaxo Group Ltd Compounds having affinity for dopamine d3 receptor and uses thereof
US7989444B2 (en) 2004-06-02 2011-08-02 Glaxo Group Limited Compounds having affinity for dopamine D3 receptor and uses thereof

Also Published As

Publication number Publication date
PT67260B (en) 1979-04-18
HU176709B (en) 1981-04-28
FI773448A (fi) 1978-05-18
NL930026I1 (nl) 1993-06-01
AR224495A1 (es) 1981-12-15
NL7712567A (nl) 1978-05-19
DE2751258C2 (US20080293856A1-20081127-C00150.png) 1990-01-04
YU40490B (en) 1986-02-28
SE436646B (sv) 1985-01-14
PH14740A (en) 1981-11-20
ZA775910B (en) 1978-05-30
US4160765A (en) 1979-07-10
JPS6125697B2 (US20080293856A1-20081127-C00150.png) 1986-06-17
IL53377A (en) 1982-09-30
BG30019A3 (en) 1981-03-16
IL53377A0 (en) 1978-01-31
SG31784G (en) 1985-03-08
GB1595502A (en) 1981-08-12
LU78513A1 (US20080293856A1-20081127-C00150.png) 1978-03-20
IN150172B (US20080293856A1-20081127-C00150.png) 1982-04-07
JPS62155218A (ja) 1987-07-10
AU509754B2 (en) 1980-05-22
FI67374B (fi) 1984-11-30
JPS6366808B2 (US20080293856A1-20081127-C00150.png) 1988-12-22
NO147029C (no) 1983-01-19
IE46087B1 (en) 1983-02-23
IT1126216B (it) 1986-05-14
CH635079A5 (de) 1983-03-15
NL930026I2 (nl) 1993-11-01
PL202177A1 (pl) 1978-09-25
NL185563B (nl) 1989-12-18
AT362379B (de) 1981-05-11
CS219333B2 (en) 1983-03-25
FI67374C (fi) 1985-03-11
SU976847A3 (ru) 1982-11-23
RO72905A (ro) 1981-11-04
NL185563C (nl) 1990-05-16
DK500477A (da) 1978-05-18
ES464044A1 (es) 1978-08-01
BE860774A (fr) 1978-05-16
JPS5363335A (en) 1978-06-06
MY8500382A (en) 1985-12-31
DD133563A5 (de) 1979-01-10
SE7712944L (sv) 1978-05-18
NO147029B (no) 1982-10-11
CY1246A (en) 1984-08-31
JPS58113153A (ja) 1983-07-05
YU270777A (en) 1983-02-28
NO773901L (no) 1978-05-19
MX4682E (es) 1982-07-28
AU3062677A (en) 1979-05-24
DK156057B (da) 1989-06-19
JPS6225658B2 (US20080293856A1-20081127-C00150.png) 1987-06-04
IE46087L (en) 1978-05-17
PL109672B1 (en) 1980-06-30
ATA816377A (de) 1980-10-15
PH13611A (en) 1980-08-05
FR2371430B1 (US20080293856A1-20081127-C00150.png) 1980-06-27
DK156057C (da) 1989-11-13
CA1092107A (en) 1980-12-23
FR2371430A1 (fr) 1978-06-16
PT67260A (en) 1977-12-01

Similar Documents

Publication Publication Date Title
DE2751258A1 (de) Trisubstituierte 1-phenyl-2,3,4,5- tetrahydro-1h-3-benzazepine und deren salze, verfahren zu ihrer herstellung und ihre verwendung als arzneistoffe
DE2804285C2 (US20080293856A1-20081127-C00150.png)
DE2411382B2 (de) 2-Tetrahydrofurfuryl-6,7-benzomorphane, Verfahren zur Herstellung und deren Verwendung
DE2437610A1 (de) Neue 5,9-beta-disubstituierte 2-tetrahydrofurfuryl-6,7-benzomorphane, deren saeureadditionssalze, ihre verwendung als arzneimittel und verfahren zu deren herstellung
DE1795132A1 (de) Verfahren zur Herstellung eines neuen Tetrahydroazepinderivates
CH649553A5 (de) Azepinoindole und verfahren zu deren herstellung.
DE68913367T2 (de) Benzazepinderivate.
EP0155903B1 (de) Indolophenanthridine, ihre Herstellung und Verwendung
DE2802087A1 (de) 1-phenyl-2,3,4,5-tetrahydro-1h- 3-benzazepine
DE3204157A1 (de) Substituierte dibenzodiazepinone, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE2817661A1 (de) Neue isoindolinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen
CH637383A5 (en) Trisubstituted 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines, and their salts
DE2745742A1 (de) Piperidylidenderivate von benzoxanthenen, -thioxanthenen und -dibenzoxepinen, verfahren zu deren herstellung und deren verwendung als psychopharmaca
DE2849766A1 (de) 6-nieder-alkyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine sowie deren salze mit saeuren und ihre verwendung als dopaminerge wirkstoffe
CA1136134A (en) 1-hydroxyalkanamine tetrahydrocarbazoles
DE1963205C3 (de) Basisch substituierte Benzo eckige Klammer auf b eckige Klammer zu benzofurane eckige Klammer auf 2,3,-e eckige Klammer zu oxepine und deren pharmakologisch verträgliche Säureadditionssalze sowie Arzneimittel mit einem Gehalt dieser Verbindungen
CH642634A5 (en) 1-Phenyl-2,3,4,5-tetrahydro-7,8-dihydroxy-1H-3-benzazepines
DE3700825A1 (de) 8(alpha)-acylaminoergoline, ihre herstellung und verwendung
DE2209844C3 (de) 4-(Alkylamino-alkyl)- [4H] -thieno [3,2-b] [f] benzazepine, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen
EP0483063B1 (de) Ergolinderivate
DE3129527A1 (de) "phosphoniumsalze"
DE2245141A1 (de) Neue n-(heteroarylmethyl)-desoxynormorphine und -norcodeine, deren saeureadditionssalze, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
AT359511B (de) Verfahren zur herstellung von neuen 1-(2'- thienyl)-und 1-(2'-furyl)-2,3,4,5-tetrahydro-1h -3-benzazepinen und von ihren salzen
DE1795758A1 (de) Verfahren zur herstellung von 5hydroxy-5-phenyl-2,3-dihydro-5h-imidazo eckige klammer auf 2,1-a eckige klammer zu isoindolen
AT251572B (de) Verfahren zur Herstellung von neuen Thieno-benzothiazin-Derivaten

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8127 New person/name/address of the applicant

Owner name: SMITHKLINE BECKMAN CORP., 19101 PHILADELPHIA, PA.,

8128 New person/name/address of the agent

Representative=s name: VOSSIUS, V., DIPL.-CHEM. DR.RER.NAT. VOSSIUS, D.,

8128 New person/name/address of the agent

Representative=s name: VOSSIUS, V., DIPL.-CHEM. DR.RER.NAT. TAUCHNER, P.,

D2 Grant after examination
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Free format text: TAUCHNER, P., DIPL.-CHEM. DR.RER.NAT., PAT.-ANW., 8000 MUENCHEN